Gangtong Medical(301515.SZ)

Company Encyclopedia
View More
name
Gangtong Medical
301515.SZ
Sichuan Gangtong Medical Equipment Group Co., Ltd. engages in the research and development, design, manufacturing, integration, operation, and maintenance of medical gas and cleaning equipment and systems in China and internationally. It offers medical central oxygen supply systems, medical central suction systems, medical air centralized supply systems, medical gas alarm systems, medical molecular sieve oxygen production systems, medical vacuum negative pressure machines, electric hydraulic operating tables, surgical shadowless lamps, and other medical devices, as well as medical liquid oxygen storage tanks, medical gas terminals, medical airtight doors, and other medical equipment. The company was founded in 1998 and is headquartered in Jianyang, China.
958.46 B
301515.SZMarket value -Rank by Market Cap -/-

Financial Score

12/01/2026 Update
D
Health Care EquipmentIndustry
Industry Ranking63/63
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-1.25%D
    • Profit Margin-2.61%D
    • Gross Margin23.49%D
  • Growth ScoreE
    • Revenue YoY-32.70%E
    • Net Profit YoY-124.23%E
    • Total Assets YoY7.46%B
    • Net Assets YoY-7.09%D
  • Cash ScoreE
    • Cash Flow Margin-3827.98%E
    • OCF YoY-32.70%E
  • Operating ScoreD
    • Turnover0.3D
  • Debt ScoreC
    • Gearing Ratio40.94%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Gangtong Medical released its performance for the first three quarters, with a net loss attributable to the parent company of 10.2084 million yuan

    According to the Zhitong Finance APP, Gangtong Medical released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 344 million yuan, a year-on-year decrease of 30.06%. The net loss attributable to shareholders of the listed company was 10.2084 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 12.8652 million yuan. The basic loss per share was 0.1054 yuan

    Zhitong·
    SZ
    301515
    +5.74%
    Zhitong·
    SZ
    301515
    +5.74%

    Gangtong Medical plans to invest 150 million yuan in Chengdu Rongchuang Gangtong, focusing on the medical-related field

    Gangtong Medical plans to establish the Chengdu Rongchuang Gangtong Equity Investment Fund in collaboration with multiple investment institutions, with a total subscribed capital of 500 million yuan, of which Gangtong Medical will contribute 150 million yuan, accounting for 30%. The fund will focus on investing in fields such as medical devices, medical equipment, and medical services, with strategic directions including high-end medical devices, AI healthcare, and smart wards

    Zhitong·
    SZ
    301515
    +5.74%
    Zhitong·
    SZ
    301515
    +5.74%

    Gangtong Medical plans to launch a restricted stock incentive plan in 2025

    Gangtong Medical released a draft of the 2025 restricted stock incentive plan, proposing to grant 1.23 million restricted shares, accounting for 1.23% of the company's total share capital. The grant price is set at 10.13 yuan per share, and the plan has a maximum validity period of 48 months

    Zhitong·
    SZ
    301515
    +5.74%
    Zhitong·
    SZ
    301515
    +5.74%

    Gangtong Medical released its first-quarter performance, with a net profit attributable to the parent company of 1.579 million yuan, a year-on-year decrease of 85.25%

    According to the Zhitong Finance APP, Gangtong Medical released its Q1 2025 report. In the first quarter, the company achieved operating revenue of 24.2867 million yuan, a year-on-year decrease of 68.09%. The net profit attributable to shareholders of the listed company was 1.579 million yuan, a year-on-year decrease of 85.25%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 1.4143 million yuan, a year-on-year decrease of 86.46%

    Zhitong·
    SZ
    301515
    +5.74%
    Zhitong·
    SZ
    301515
    +5.74%

    Gangtong Medical released its 2024 annual performance, with a net profit attributable to the parent company of 14.4219 million yuan, a year-on-year decrease of 82.64%

    Gangtong Medical released its 2024 annual report, with operating revenue of 754 million yuan, a year-on-year decrease of 10.49%; net profit attributable to the parent company was 14.4219 million yuan, a year-on-year decrease of 82.64%; net profit after deducting non-recurring gains and losses was 5.0084 million yuan, a year-on-year decrease of 91.74%; basic earnings per share were 0.1453 yuan

    Zhitong·
    SZ
    301515
    +5.74%
    Zhitong·
    SZ
    301515
    +5.74%
    © 2026 Longbridge｜Disclaimer